The DOI matches its Crossref record; 158 of the 158 references it cites were found in a registry or an index.
Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes
Open accessAbstract
Breast cancer is a complex disease encompassing multiple tumor entities, each characterized by distinct morphology, behavior and clinical implications. Besides estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2, novel biomarkers have shown their prognostic and predictive values, complicating our understanding towards to the heterogeneity of such cancers. Ten cancer hallmarks have been proposed by Weinberg to characterize cancer and its carcinogenesis. By reviewing biomarkers and breast cancer molecular subtypes, we propose that the divergent outcome observed from patients stratified by hormone status are driven by different cancer hallmarks. 'Sustaining proliferative signaling' further differentiates cancers with positive hormone receptors. 'Activating invasion and metastasis' and 'evading immune destruction' drive the differentiation of triple negative breast cancers. 'Resisting cell death', 'genome instability and mutation' and 'deregulating cellular energetics' refine breast cancer classification with their predictive values. 'Evading growth suppressors', 'enabling replicative immortality', 'inducing angiogenesis' and 'tumor-promoting inflammation' have not been involved in breast cancer classification which need more focus in the future biomarker-related research. This review novels in its global view on breast cancer heterogeneity, which clarifies many confusions in this field and contributes to precision medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500
Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938
Lehmann, B. D., Bauer, J. A., Chen, X., Sanders, M. E., Chakravarthy, A. B., Shyr, Y., & Pietenpol, J. A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45014 · Cited by 5,592
Repeated observation of breast tumor subtypes in independent gene expression data sets
Sørlie, T., Tibshirani, R., Parker, J., Hastie, T., Marron, J. S., Nobel, A., Deng, S., Johnsen, H., Pesich, R., Geisler, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932692100 · Cited by 5,429
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
Piccart-Gebhart, M. J., Procter, M., Leyland-Jones, B., Goldhirsch, A., Untch, M., Smith, I., Gianni, L., Baselga, J., Bell, R., Jackisch, C., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052306 · Cited by 5,084
Wolff, A. C., Hammond, M. E. H., Schwartz, J. N., Hagerty, K. L., Allred, D. C., Cote, R. J., Dowsett, M., Fitzgibbons, P. L., Hanna, W. M., Langer, A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.2775 · Cited by 4,434
Trastuzumab-Induced Hepatotoxicity: A Case Report
Vucicevic, D., Carey, E. J., & Karlin, N. J. (2013) · Breast Care · doi:10.1159/000346844 · Cited by 4,415
Elkablawy, M. A., Albasri, A. M., Mohammed, R. A., Hussainy, A. S., Nouh, M. M., & Alhujaily, A. S. (2016) · Saudi Medical Journal · doi:10.15537/smj.2016.2.12285 · Cited by 4,382
Tamoxifen for early breast cancer: an overview of the randomised trials
(1998) · The Lancet · doi:10.1016/s0140-6736(97)11423-4 · Cited by 4,085
Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study
Carey, L. A., Perou, C. M., Livasy, C. A., Dressler, L. G., Cowan, D., Conway, K., Karaca, G., Troester, M. A., Tse, C. K., Edmiston, S., et al. (2006) · JAMA · doi:10.1001/jama.295.21.2492 · Cited by 3,819
Nielsen, T. O., Hsu, F. D., Jensen, K., Cheang, M., Karaca, G., Hu, Z., Hernandez-Boussard, T., Livasy, C., Cowan, D., Dressler, L., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0220 · Cited by 2,663
Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases
Carter, C. L., Allen, C., & Henson, D. E. (1989) · Cancer · doi:10.1002/1097-0142(19890101)63:1<181::aid-cncr2820630129>3.0.co;2-h · Cited by 2,288
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
Cheang, M. C. U., Chia, S. K., Voduc, D., Gao, D., Leung, S., Snider, J., Watson, M., Davies, S., Bernard, P. S., Parker, J. S., et al. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp082 · Cited by 2,249
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
Prat, A., Parker, J. S., Karginova, O., Fan, C., Livasy, C., Herschkowitz, J. I., He, X., & Perou, C. M. (2010) · Breast Cancer Research · doi:10.1186/bcr2635 · Cited by 2,167
Sotiriou, C., Wirapati, P., Loi, S., Harris, A., Fox, S., Smeds, J., Nordgren, H., Farmer, P., Praz, V., Haibe-Kains, B., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj052 · Cited by 2,063
Sotiriou, C., Neo, S.-Y., McShane, L. M., Korn, E. L., Long, P. M., Jazaeri, A., Martiat, P., Fox, S. B., Harris, A. L., & Liu, E. T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1732912100 · Cited by 1,993
Wolff, A. C., Hammond, M. E. H., Schwartz, J. N., Hagerty, K. L., Allred, D. C., Cote, R. J., Dowsett, M., Fitzgibbons, P. L., Hanna, W. M., Langer, A., et al. (2007) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2007-131-18-asocco · Cited by 1,816
The molecular portraits of breast tumors are conserved across microarray platforms
Hu, Z., Fan, C., Oh, D. S., Marron, J., He, X., Qaqish, B. F., Livasy, C., Carey, L. A., Reynolds, E., Dressler, L., et al. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-96 · Cited by 1,491
Gene-Expression Signatures in Breast Cancer
Sotiriou, C., & Pusztai, L. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0801289 · Cited by 1,485
Creighton, C. J., Li, X., Landis, M., Dixon, J. M., Neumeister, V. M., Sjolund, A., Rimm, D. L., Wong, H., Rodriguez, A., Herschkowitz, J. I., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905718106 · Cited by 1,412
Deconstructing the molecular portraits of breast cancer
Prat, A., & Perou, C. M. (2011) · Molecular Oncology · doi:10.1016/j.molonc.2010.11.003 · Cited by 1,343
Concordance among Gene-Expression–Based Predictors for Breast Cancer
Fan, C., Oh, D. S., Wessels, L., Weigelt, B., Nuyten, D. S. A., Nobel, A. B., van't Veer, L. J., & Perou, C. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052933 · Cited by 1,341
Genomic and transcriptional aberrations linked to breast cancer pathophysiologies
Chin, K., DeVries, S., Fridlyand, J., Spellman, P. T., Roydasgupta, R., Kuo, W.-L., Lapuk, A., Neve, R. M., Qian, Z., Ryder, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.009 · Cited by 1,317
McDonnell, T. J., Deane, N., Platt, F. M., Nunez, G., Jaeger, U., McKearn, J. P., & Korsmeyer, S. J. (1989) · Cell · doi:10.1016/0092-8674(89)90174-8 · Cited by 1,213
Cheang, M. C. U., Voduc, D., Bajdik, C., Leung, S., McKinney, S., Chia, S. K., Perou, C. M., & Nielsen, T. O. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1658 · Cited by 1,195
Henderson, S., Rowe, M., Gregory, C., Croom-Carter, D., Wang, F., Longnecker, R., Kieff, E., & Rickinson, A. (1991) · Cell · doi:10.1016/0092-8674(91)90007-l · Cited by 1,168
Blows, F. M., Driver, K. E., Schmidt, M. K., Broeks, A., van Leeuwen, F. E., Wesseling, J., Cheang, M. C., Gelmon, K., Nielsen, T. O., Blomqvist, C., et al. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000279 · Cited by 1,116
Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma
Livasy, C. A., Karaca, G., Nanda, R., Tretiakova, M. S., Olopade, O. I., Moore, D. T., & Perou, C. M. (2006) · Modern Pathology · doi:10.1038/modpathol.3800528 · Cited by 1,063
Ellis, M. J., Coop, A., Singh, B., Mauriac, L., Llombert-Cussac, A., Jänicke, F., Miller, W. R., Evans, D. B., Dugan, M., Brady, C., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.18.3808 · Cited by 1,060
Prognostic Factors in Breast Cancer: College of American Pathologists Consensus Statement 1999
Fitzgibbons, P. L., Page, D. L., Weaver, D., Thor, A. D., Allred, D. C., Clark, G. M., Ruby, S. G., O'Malley, F., Simpson, J. F., Connolly, J. L., et al. (2000) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2000-124-0966-pfibc · Cited by 1,016
Breast Cancer Research and Treatment
Alexander, M. (1999) · Breast Cancer Research and Treatment · doi:10.1023/a:1006151427889 · Cited by 997
MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype
Blenkiron, C., Goldstein, L. D., Thorne, N. P., Spiteri, I., Chin, S.-F., Dunning, M. J., Barbosa-Morais, N. L., Teschendorff, A. E., Green, A. R., Ellis, I. O., et al. (2007) · Genome Biology · doi:10.1186/gb-2007-8-10-r214 · Cited by 948
Goldhirsch, A., Wood, W. C., Gelber, R. D., Coates, A. S., Thürlimann, B., & Senn, H.-J. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm271 · Cited by 944
Howell, A. (1998) · PubMed · Cited by 901
Wirapati, P., Sotiriou, C., Kunkel, S., Farmer, P., Pradervand, S., Haibe-Kains, B., Desmedt, C., Ignatiadis, M., Sengstag, T., Schütz, F., et al. (2008) · Breast Cancer Research · doi:10.1186/bcr2124 · Cited by 891
Hennessy, B. T., Gonzalez-Angulo, A.-M., Stemke-Hale, K., Gilcrease, M. Z., Krishnamurthy, S., Lee, J.-S., Fridlyand, J., Sahin, A., Agarwal, R., Joy, C., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3441 · Cited by 874
Loi, S., Haibe-Kains, B., Desmedt, C., Lallemand, F., Tutt, A. M., Gillet, C., Ellis, P., Harris, A., Bergh, J., Foekens, J. A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.1522 · Cited by 837
Dunnwald, L. K., Rossing, M. A., & Li, C. I. (2007) · Breast Cancer Research · doi:10.1186/bcr1639 · Cited by 785
Identification of molecular apocrine breast tumours by microarray analysis
Farmer, P., Bonnefoi, H., Becette, V., Tubiana-Hulin, M., Fumoleau, P., Larsimont, D., MacGrogan, G., Bergh, J., Cameron, D., Goldstein, D., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208561 · Cited by 785
Bardou, V.-J., Arpino, G., Elledge, R. M., Osborne, C. K., & Clark, G. M. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.09.099 · Cited by 752
The value of estrogen and progesterone receptors in the treatment of breast cancer
Osborne, C. K., Yochmowitz, M. G., Knight, W. A., & McGuire, W. L. (1980) · Cancer · doi:10.1002/1097-0142(19801215)46:12+<2884::aid-cncr2820461429>3.0.co;2-u · Cited by 720
Ellis, M. J., Tao, Y., Luo, J., A'Hern, R., Evans, D. B., Bhatnagar, A. S., Chaudri Ross, H. A., von Kameke, A., Miller, W. R., Smith, I., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn309 · Cited by 653
erbB-2, p53, and Efficacy of Adjuvant Therapy in Lymph Node-Positive Breast Cancer
Thor, A. D., Berry, D. A., Budman, D. R., Muss, H. B., Kute, T., Henderson, I. C., Barcos, M., Cirrincione, C., Edgerton, S., Allred, C., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.18.1346 · Cited by 612
HER2 and Response to Paclitaxel in Node-Positive Breast Cancer
Hayes, D. F., Thor, A. D., Dressler, L. G., Weaver, D., Edgerton, S., Cowan, D., Broadwater, G., Goldstein, L. J., Martino, S., Ingle, J. N., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071167 · Cited by 608
The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer.
Olivier, M., Langer√∏d, A., Carrieri, P., Bergh, J., Klaar, S., Eyfjord, J., Theillet, C., Rodriguez, C., Lidereau, R., Bi√®che, I., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1029 · Cited by 589
Konecny, G., Pauletti, G., Pegram, M., Untch, M., Dandekar, S., Aguilar, Z., Wilson, C., Rong, H.-M., Bauerfeind, I., Felber, M., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.2.142 · Cited by 588
Anderson, W. F., Chatterjee, N., Ershler, W. B., & Brawley, O. W. (2002) · Breast Cancer Research and Treatment · doi:10.1023/a:1020299707510 · Cited by 585
Molecular Stratification of Triple-Negative Breast Cancers
Perou, C. M. (2011) · The Oncologist · doi:10.1634/theoncologist.2011-s1-61 · Cited by 582
Dose and Dose Intensity of Adjuvant Chemotherapy for Stage II, Node-Positive Breast Carcinoma
Wood, W. C., Budman, D. R., Korzun, A. H., Cooper, M. R., Younger, J., Hart, R. D., Moore, A., Ellerton, J. A., Norton, L., Ferree, C. R., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199405053301801 · Cited by 577
BRCA1 dysfunction in sporadic basal-like breast cancer
Turner, N. C., Reis-Filho, J. S., Russell, A. M., Springall, R. J., Ryder, K., Steele, D., Savage, K., Gillett, C. E., Schmitt, F. C., Ashworth, A., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210014 · Cited by 573
Dose and Dose Intensity of Adjuvant Chemotherapy for Stage II, Node-Positive Breast Carcinoma
(1994) · New England Journal of Medicine · doi:10.1056/nejm199407143310226 · Cited by 556
HER2 and Responsiveness of Breast Cancer to Adjuvant Chemotherapy
Pritchard, K. I., Shepherd, L. E., O'Malley, F. P., Andrulis, I. L., Tu, D., Bramwell, V. H., & Levine, M. N. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054504 · Cited by 509
Teschendorff, A. E., Miremadi, A., Pinder, S. E., Ellis, I. O., & Caldas, C. (2007) · Genome Biology · doi:10.1186/gb-2007-8-8-r157 · Cited by 497
Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes
Rakha, E. A., Elsheikh, S. E., Aleskandarany, M. A., Habashi, H. O., Green, A. R., Powe, D. G., El-Sayed, M. E., Benhasouna, A., Brunet, J.-S., Akslen, L. A., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2132 · Cited by 489
Arpino, G., Weiss, H., Lee, A. V., Schiff, R., De Placido, S., Osborne, C. K., & Elledge, R. M. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji249 · Cited by 484
Weigelt, B., Baehner, F. L., & Reis‐Filho, J. S. (2010) · The Journal of Pathology · doi:10.1002/path.2648 · Cited by 482
Down-regulation of bcl-2 by p53 in breast cancer cells.
Haldar, S., Negrini, M., Monne, M. I., Sabbioni, S., & Croce, C. M. (1994) · PubMed · Cited by 471
Histological and molecular types of breast cancer: is there a unifying taxonomy?
Weigelt, B., & Reis-Filho, J. S. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.166 · Cited by 457
Silvestrini, R., Veneroni, S., Daidone, M. G., Benini, E., Boracchi, P., Mezzetti, M., di Fronzo, G., Rilke, F. O., & Veronesi, U. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.7.499 · Cited by 454
Viale, G., Regan, M. M., Maiorano, E., Mastropasqua, M. G., Dell'Orto, P., Rasmussen, B. B., Raffoul, J., Neven, P., Orosz, Z., Braye, S., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.9453 · Cited by 452
Comprehensive molecular portraits of human breast tumours
McCullough, A. (2013) · Yearbook of Pathology and Laboratory Medicine · doi:10.1016/j.ypat.2012.10.013 · Cited by 441
Molecular portraits of breast cancer: tumour subtypes as distinct disease entities
Sørlie, T. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.08.021 · Cited by 415
HORWITZ, K. B., KOSEKI, Y., & McGUIRE, W. L. (1978) · Endocrinology · doi:10.1210/endo-103-5-1742 · Cited by 415
Targeting Androgen Receptor in Estrogen Receptor-Negative Breast Cancer
Ni, M., Chen, Y., Lim, E., Wimberly, H., Bailey, S. T., Imai, Y., Rimm, D. L., Shirley Liu, X., & Brown, M. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.05.026 · Cited by 397
Bcl-2 protein expression and long-term survival in breast cancer.
Joensuu, H., Pylkkänen, L. H., & Toikkanen, S. (1994) · PubMed · Cited by 396
Androgen Receptor Expression and Breast Cancer Survival in Postmenopausal Women
Hu, R., Dawood, S., Holmes, M. D., Collins, L. C., Schnitt, S. J., Cole, K., Marotti, J. D., Hankinson, S. E., Colditz, G. A., & Tamimi, R. M. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2021 · Cited by 396
Prognostic value of proliferation in invasive breast cancer: a review: Table 1
van Diest, P. J., van der Wall, E., & Baak, J. P. A. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.010777 · Cited by 385
p53 and breast cancer, an update
Lacroix, M., Toillon, R.-A., & Leclercq, G. (2006) · Endocrine-Related Cancer · doi:10.1677/erc.1.01172 · Cited by 380
Plasma 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D and Risk of Breast Cancer
Bertone-Johnson, E. R., Chen, W. Y., Holick, M. F., Hollis, B. W., Colditz, G. A., Willett, W. C., & Hankinson, S. E. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0722 · Cited by 357
Estrogen-Regulated Genes Predict Survival in Hormone Receptor–Positive Breast Cancers
Oh, D. S., Troester, M. A., Usary, J., Hu, Z., He, X., Fan, C., Wu, J., Carey, L. A., & Perou, C. M. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.2755 · Cited by 356
Børresen-Dale, A.-L. (2003) · Human Mutation · doi:10.1002/humu.10174 · Cited by 354
Fulford, L. G., Easton, D. F., Reis‐Filho, J. S., Sofronis, A., Gillett, C. E., Lakhani, S. R., & Hanby, A. (2006) · Histopathology · doi:10.1111/j.1365-2559.2006.02453.x · Cited by 352
Viale, G., Giobbie-Hurder, A., Regan, M. M., Coates, A. S., Mastropasqua, M. G., Dell'Orto, P., Maiorano, E., MacGrogan, G., Braye, S. G., Öhlschlegel, C., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.0829 · Cited by 340
Cell-type specific gene expression profiles of leukocytes in human peripheral blood
Palmer, C., Diehn, M., Alizadeh, A. A., & Brown, P. O. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-115 · Cited by 331
Elledge, R. M., Green, S., Pugh, R., Allred, D. C., Clark, G. M., Hill, J., Ravdin, P., Martino, S., & Osborne, C. K. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000320)89:2<111::aid-ijc2>3.0.co;2-w · Cited by 325
Knoop, A. S., Knudsen, H., Balslev, E., Rasmussen, B. B., Overgaard, J., Nielsen, K. V., Schonau, A., Gunnarsdóttir, K., Olsen, K. E., Mouridsen, H., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.11.007 · Cited by 320
Dawson, S.-J., Makretsov, N., Blows, F. M., Driver, K. E., Provenzano, E., Le Quesne, J., Baglietto, L., Severi, G., Giles, G. G., McLean, C. A., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605736 · Cited by 317
Identification of molecular apocrine breast tumours by microarray analysis
Farmer, P., Bonnefoi, H., Becette, V, Tubiana-Hulin, M., Fumoleau, P., Larsimont, D., MacGrogan, G., Bergh, J., Cameron, D., Goldstein, D., et al. (2005) · Breast Cancer Research · doi:10.1186/bcr1122 · Cited by 307
Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?
Colozza, M., Azambuja, E., Cardoso, F., Sotiriou, C., Larsimont, D., & Piccart, M. J. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi352 · Cited by 307
Chia, S., Norris, B., Speers, C., Cheang, M., Gilks, B., Gown, A. M., Huntsman, D., Olivotto, I. A., Nielsen, T. O., & Gelmon, K. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.8659 · Cited by 301
Triple-negative/basal-like breast cancer: review
Rakha, E. A., & Ellis, I. O. (2009) · Pathology · doi:10.1080/00313020802563510 · Cited by 281
Kandioler-Eckersberger, D., Ludwig, C., Rudas, M., Kappel, S., Janschek, E., Wenzel, C., Schlagbauer‐Wadl, H., Mittlböck, M., Gnant, M., Steger, G., et al. (2000) · PubMed · Cited by 280
Abbas, S., Linseisen, J., Slanger, T., Kropp, S., Mutschelknauss, E. J., Flesch-Janys, D., & Chang-Claude, J. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm240 · Cited by 279
Two-Stage Model for Carcinogenesis: Epidemiology of Breast Cancer in Females 2
(1980) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/65.3.559 · Cited by 264
Dowsett, M., Cuzick, J., Wale, C., Howell, T., Houghton, J., & Baum, M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.4829 · Cited by 260
Lowe, L. C., Guy, M., Mansi, J. L., Peckitt, C., Bliss, J., Wilson, R. G., & Colston, K. W. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.01.017 · Cited by 256
Spitale, A., Mazzola, P., Soldini, D., Mazzucchelli, L., & Bordoni, A. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn675 · Cited by 246
Harris, L. N., You, F., Schnitt, S. J., Witkiewicz, A., Lu, X., Sgroi, D., Ryan, P. D., Come, S. E., Burstein, H. J., Lesnikoski, B.-A., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1304 · Cited by 245
Winger, M., Volz, T., Tarel, G., Portolan, S., Badolato, A., Hennessy, K. J., Hu, E. L., Beveratos, A., Finley, J., Savona, V., et al. (2009) · Physical Review Letters · doi:10.1103/physrevlett.103.207403 · Cited by 227
Matos, I., Dufloth, R., Alvarenga, M., Zeferino, L. C., & Schmitt, F. (2005) · Virchows Archiv · doi:10.1007/s00428-005-0010-7 · Cited by 227
Combinatorial biomarker expression in breast cancer
Rakha, E. A., Reis-Filho, J. S., & Ellis, I. O. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0746-x · Cited by 219
Press, M. F., Sauter, G., Buyse, M., Bernstein, L., Guzman, R., Santiago, A., Villalobos, I. E., Eiermann, W., Pienkowski, T., Martin, M., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.5644 · Cited by 219
Measurement of steroid hormone receptors in breast cancer patients on tamoxifen
Encarnaci�n, C. A., Ciocca, D. R., McGuire, W. L., Clark, G. M., Fuqua, S. A. W., & Osborne, C. K. (1993) · Breast Cancer Research and Treatment · doi:10.1007/bf00665801 · Cited by 194
Determination of Stromal Signatures in Breast Carcinoma
West, R. B., Nuyten, D. S. A., Subramanian, S., Nielsen, T. O., Corless, C. L., Rubin, B. P., Montgomery, K., Zhu, S., Patel, R., Hernandez-Boussard, T., et al. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030187 · Cited by 194
Taxonomy of breast cancer based on normal cell phenotype predicts outcome
Santagata, S., Thakkar, A., Ergonul, A., Wang, B., Woo, T., Hu, R., Harrell, J. C., McNamara, G., Schwede, M., Culhane, A. C., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci70941 · Cited by 193
Ogawa, Y., Hai, E., Matsumoto, K., Ikeda, K., Tokunaga, S., Nagahara, H., Sakurai, K., Inoue, T., & Nishiguchi, Y. (2008) · International Journal of Clinical Oncology · doi:10.1007/s10147-008-0770-6 · Cited by 184
Novel Prognostic Immunohistochemical Biomarker Panel for Estrogen Receptor–Positive Breast Cancer
Ring, B. Z., Seitz, R. S., Beck, R., Shasteen, W. J., Tarr, S. M., Cheang, M. C. U., Yoder, B. J., Budd, G. T., Nielsen, T. O., Hicks, D. G., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.6564 · Cited by 181
HER-2 and Topoisomerase II As Predictors of Response to Chemotherapy
Pritchard, K. I., Messersmith, H., Elavathil, L., Trudeau, M., O’Malley, F., & Dhesy-Thind, B. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.4716 · Cited by 176
Proliferation index as a prognostic marker in breast cancer
Veronese, S. M., Gambacorta, M., Gottardi, O., Scanzi, F., Ferrari, M., & Lampertico, P. (1993) · Cancer · Cited by 175
Vallejos, C. S., Gómez, H. L., Cruz, W. R., Pinto, J. A., Dyer, R. R., Velarde, R., Suazo, J. F., Neciosup, S. P., León, M., de la Cruz, M. A., et al. (2010) · Clinical Breast Cancer · doi:10.3816/cbc.2010.n.038 · Cited by 171
Tiling Path Genomic Profiling of Grade 3 Invasive Ductal Breast Cancers
Natrajan, R., Lambros, M. B., Rodríguez-Pinilla, S. M., Moreno-Bueno, G., Tan, D. S. P., Marchió, C., Vatcheva, R., Rayter, S., Mahler-Araujo, B., Fulford, L. G., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1878 · Cited by 170
Rakha, E. A., El‐Sayed, M. E., Green, A. R., Paish, E. C., Lee, A. H. S., & Ellis, I. O. (2007) · Histopathology · doi:10.1111/j.1365-2559.2007.02638.x · Cited by 169
Design of a National Distributed Health Data Network
Maro, J. C., Platt, R., Holmes, J. H., Strom, B. L., Hennessy, S., Lazarus, R., & Brown, J. S. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-5-200909010-00139 · Cited by 165
Regan, M. M., Viale, G., Mastropasqua, M. G., Maiorano, E., Golouh, R., Carbone, A., Brown, B., Suurküla, M., Langman, G., Mazzucchelli, L., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj415 · Cited by 164
1–1 Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study
(2007) · Breast Diseases A Year Book Quarterly · doi:10.1016/s1043-321x(07)80006-3 · Cited by 159
Lipponen, P., Pietiläinen, T., Kosma, V., Aaltomaa, S. H., Eskelinen, M., & Syrjäunen, K. (1995) · The Journal of Pathology · doi:10.1002/path.1711770109 · Cited by 156
HER-2/neu Gene Amplification and Response to Paclitaxel in Patients With Metastatic Breast Cancer
Konecny, G., Thomssen, C., Lück, H., Untch, M., Wang, H.-J., Kuhn, W. C., Eidtmann, H., Bois, A. D., Olbricht, S., Steinfeld, D., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh198 · Cited by 156
Stendahl, M., Rydén, L., Nordenskjöld, B. A., Jönsson, P., Landberg, G., & Jirström, K. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0248 · Cited by 155
Natrajan, R., Weigelt, B., Mackay, A. G., Geyer, F. C., Grigoriadis, A. E., Tan, D. S. P., Jones, C., Lord, C. J., Vatcheva, R., Rodríguez-Pinilla, S. M., et al. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0501-3 · Cited by 153
Parl, F. F., Schmidt, B. P., Dupont, W. D., & Wagner, R. K. (1984) · Cancer · Cited by 146
The clinical evaluation of HER‐2 status: which test to use?
Bartlett, J. M. S., Mallon, E., & Cooke, T. (2003) · The Journal of Pathology · doi:10.1002/path.1354 · Cited by 142
Anderson, W. F., Chu, K. C., Chatterjee, N., Brawley, O. W., & Brinton, L. A. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.1.18 · Cited by 140
Sayeed, A., Konduri, S. D., Liu, W., Bansal, S., Li, F., & Das, G. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3724 · Cited by 135
bcl-2 and apoptosis in lymph node positive breast carcinoma
Berardo, M. D., Elledge, R. M., de Moor, C., Clark, G. M., Osborne, C. K., & Allred, D. C. (1998) · Cancer · Cited by 130
Lippman, M. E., BOLAN, G. A., & Huff, K. K. (1976) · PubMed · Cited by 127
Römer, D., Sznitman, S. R., DiClemente, R. J., Salazar, L. F., Vanable, P. A., Carey, M. P., Hennessy, M. H., Brown, L. K., Valois, R. F., STANTON, B. F., et al. (2009) · American Journal of Public Health · doi:10.2105/ajph.2008.155036 · Cited by 125
Quach, S., Hennessy, D. A., Faris, P., Fong, A., Quan, H., & Doig, C. J. (2009) · BMC Health Services Research · doi:10.1186/1472-6963-9-129 · Cited by 122
Nielsen, K. V., Ejlertsen, B., Möller, S., Jørgensen, J. T., Knoop, A. S., Knudsen, H., & Mouridsen, H. T. (2008) · Acta Oncologica · doi:10.1080/02841860801995396 · Cited by 110
Vanhaesebroeck, B., Reed, J. C., VALCK, D. D., et al. (1993) · PubMed · Cited by 106
The MPA mouse breast cancer model: evidence for a role of progesterone receptors in breast cancer
Lanari, C., Lamb, C. A., Fabris, V. T., Helguero, L. A., Soldati, R., Bottino, M. C., Giulianelli, S., Cerliani, J. P., Wargon, V., & Molinolo, A. (2009) · Endocrine Related Cancer · doi:10.1677/erc-08-0244 · Cited by 103
Metaplastic Breast Cancer: Clinical Features and Outcomes
Gibson, G. R., Qian, D., Ku, J. K., & Lai, L. L. (2005) · The American Surgeon · doi:10.1177/000313480507100906 · Cited by 103
Development of the rural active living assessment tools: Measuring rural environments
Yousefian, A. E., Hennessy, E., Umstattd, M. R., Economos, C. D., Hallam, J. S., Hyatt, R. R., & Hartley, D. (2009) · Preventive Medicine · doi:10.1016/j.ypmed.2009.08.018 · Cited by 100
Genome-Wide Functional Synergy between Amplified and Mutated Genes in Human Breast Cancer
Nikolsky, Y., Sviridov, E., Yao, J., Dosymbekov, D., Ustyansky, V., Kaznacheev, V., Dezső, Z., Mulvey, L. A., MacConaill, L. E., Winckler, W., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-3082 · Cited by 100
Cardoso, F., Durbecq, V., Larsimont, D., Paesmans, M., Leroy, J., Rouas, G., Sotiriou, C. P., Renard, N., Richard, V., Piccart, M. J., et al. (2004) · International Journal of Oncology · doi:10.3892/ijo.24.1.201 · Cited by 94
Results of two or five years of adjuvant tamoxifen correlated to steroid receptor and S-phase levels
Fernö, M., Stål, O., Baldetrop, B., Hatschek, T., Källström, A.-C., Malmström, P., Nordenskjöld, B. A., & Rydén, S. (2000) · Breast Cancer Research and Treatment · doi:10.1023/a:1006332423620 · Cited by 94
Abdel-Fatah, T. M. A., Perry, C., Dickinson, P. D., Ball, G., Moseley, P. M., Madhusudan, S., Ellis, I. O., & Chan, S. Y. T. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt277 · Cited by 94
Role of Anthracyclines in the Treatment of Early Breast Cancer
Gianni, L., Norton, L., Wolmark, N., Suter, T. M., Bonadonna, G., & Hortobágyi, G. N. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.4791 · Cited by 91
Molecular Profiling: Moving Away from Tumor Philately
Reis-Filho, J. S., Weigelt, B., Fumagalli, D., & Sotiriou, C. P. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001329 · Cited by 90
Time to Stop Progesterone Receptor Testing in Breast Cancer Management
Olivotto, I. A., Truong, P. T., Speers, C. H., Bernstein, V., Allan, S. J., Kelly, S. J., & Lesperance, M. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.99.251 · Cited by 86
Vincent‐Salomon, A., Rousseau, A., Jouve, M., Beuzeboc, P., Sigal‐Zafrani, B., Fréneaux, P., Rosty, C., Nos, C., Campana, F., Klijanienko, J., et al. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.03.014 · Cited by 86
Immunohistochemical markers as predictive tools for breast cancer
Walker, R. A. (2007) · Journal of Clinical Pathology · doi:10.1136/jcp.2006.041830 · Cited by 84
Dai, X., Chen, A., & Bai, Z. (2014) · Scientific Reports · doi:10.1038/srep06566 · Cited by 73
Self-citationTang, P. T. P., Wang, J., & Bourne, P. (2008) · Human Pathology · doi:10.1016/j.humpath.2007.09.005 · Cited by 67
Breast cancer prognostication and prediction in the postgenomic era
Lønning, P. E., Knappskog, S., Staalesen, V., Chrisanthar, R., & Lillehaug, J. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm013 · Cited by 65
Tubbs, R., Barlow, W. E., Budd, G. T., Swain, E., Porter, P. L., Gown, A. M., Yeh, I.-T., Sledge, G. W., Shapiro, C. L., Ingle, J. N., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.1566 · Cited by 64
Prognostic influence of BCL2 expression in breast cancer
Hwang, K., Woo, J. W., Shin, H.-C., Kim, H., Ahn, S. K., Moon, H., Han, W., Park, I. A., & Noh, D. (2012) · International Journal of Cancer · doi:10.1002/ijc.27539 · Cited by 61
Predicting prognosis of breast cancer with gene signatures: are we lost in a sea of data?
Iwamoto, T., & Pusztai, L. (2010) · Genome Medicine · doi:10.1186/gm202 · Cited by 52
Charpin, C., Garcia, S., Bonnier, P., Martini, F., Andrac, L., Horschowski, N., Lavaut, M., & Allasia, C. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.6.2025 · Cited by 51
de Crémoux, P., Tran‐Perennou, C., Elie, C., Boudou, E., Barbaroux, C., Poupon, M. F., Rycke, Y. D., Asselain, B. J. R., & Magdelénat, H. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01187-5 · Cited by 45
Ihemelandu, C. U., Leffall, L. D., DeWitty, R. L., Naab, T. J., Mezghebe, H. M., Makambi, K. H., Adams-Campbell, L. L., & Frederick, W. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9477-6 · Cited by 44
Esserman, L. J., Ozanne, E. M., Dowsett, M., & Slingerland, J. M. (2005) · Breast Cancer Research · doi:10.1186/bcr1342 · Cited by 44
Bcl-2 expression correlates with lymphovascular invasion and long-term prognosis in breast cancer
Neri, A., Marrelli, D., Roviello, F., Marco, G. D., Mariani, F., Stefano, A. D., Megha, T., Caruso, S., Corso, G., Cioppa, T., et al. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9183-2 · Cited by 37
Hayes, D. F., & Paoletti, C. (2011) · Breast Diseases A Year Book Quarterly · doi:10.1016/j.breastdis.2011.03.048 · Cited by 34
Separation, Sickness, and Depression
Hennessy, M. B., Schiml‐Webb, P. A., & Terrence Deak, B. (2009) · Current Directions in Psychological Science · doi:10.1111/j.1467-8721.2009.01641.x · Cited by 33
The androgen receptor as a surrogate marker for molecular apocrine breast cancer subtyping
Lakis, S., Kotoula, V., Eleftheraki, A. G., Batistatou, A. K., Bobos, M., Κoletsa, T., Timotheadou, E. T., Chrisafi, S., Pentheroudakis, G. E., Koutras, A. K., et al. (2014) · The Breast · doi:10.1016/j.breast.2014.02.013 · Cited by 33
Development and Validation of Gene Expression Profile Signatures in Early-Stage Breast Cancer
Desmedt, C., Sotiriou, C. P., & Piccart, M. J. (2009) · Cancer Investigation · doi:10.1080/07357900802574710 · Cited by 22
Prognosis of Treatment Response (Pathological Complete Response) in Breast Cancer
Nikas, J. B., Low, W. C., & Burgio, P. A. (2012) · Biomarker Insights · doi:10.4137/bmi.s9387 · Cited by 19
Targeting Androgen Receptor in Estrogen Receptor-Negative Breast Cancer
Ni, M., Chen, Y., Lim, E., Bailey, S. T., Imai, Y., Liu, X. S., & Brown, M. A. (2011) · The Endocrine Society eBooks · doi:10.1210/endo-meetings.2011.part1.p3.p1-48 · Cited by 14
HER-2/neu gene amplification and response to paclitaxel in patients with metastatic breast cancer
(2004) · The Women s Oncology Review · doi:10.3109/14733400500034480 · Cited by 12
Sundblad, A. S., & Caprarulo, L. (1996) · PubMed · Cited by 7
Cited by
A living biobank of breast cancer organoids captures disease heterogeneity
Sachs, N., de Ligt, J., Kopper, O., Gogola, E., Bounova, G., Weeber, F., Balgobind, A. V., Wind, K., Gracanin, A., Begthel, H., et al. (2018) · Cell · doi:10.1016/j.cell.2017.11.010 · Cited by 1,973
Breast Cancer Cell Line Classification and Its Relevance with Breast Tumor Subtyping
Dai, X., Cheng, H., Bai, Z., & Li, J. (2017) · Journal of Cancer · doi:10.7150/jca.18457 · Cited by 1,100
Self-citationBreast cancer diagnosis: Imaging techniques and biochemical markers
Jafari, S. H., Saadatpour, Z., Salmaninejad, A., Momeni, F., Mokhtari, M., Nahand, J. S., Rahmati, M., Mirzaei, H., & Kianmehr, M. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26379 · Cited by 410
Gérard, C., & Brown, K. A. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.09.014 · Cited by 136
An approach for normalization and quality control for NanoString RNA expression data
Bhattacharya, A., Hamilton, A. M., Furberg, H., Pietzak, E., Purdue, M. P., Troester, M. A., Hoadley, K. A., & Love, M. I. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa163 · Cited by 122
Metadata
- Authors
- Dai, X., Xiang, L., Li, T., & Bai, Z.
- Venue
- Journal of Cancer
- Publisher
- Ivyspring International Publisher
- Published
- 2016
- Volume
- 7
- Issue
- 10
- Pages
- 1281-1294
- ISSN
- 1837-9664 (ISSN-L)
- OpenAlex
- W2461857357
- Cited by
- 440
- References
- 158
- FWCI
- 13.34
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.